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SUMMARY
Candidemia remains a major cause of morbidity and mortality in the health care environment. The epidemiology of Candida 
infection is changing, mainly in relation to the number of episodes caused by species C. non-albicans. The overall objective of this 
study was to evaluate the frequency of yeasts of the genus Candida, in a four-year period, isolated from blood of pediatric patients 
hospitalized in a public hospital of the city of São Paulo, Brazil. In this period, yeasts from blood of 104 patients were isolated and, the 
identified species of Candida by phenotypic and genotypic methods were: C. albicans (39/104), C. tropicalis (25/104), C. parapsilosis 
(23/104), Pichia anomala (6/104), C. guilliermondii (5/104), C. krusei (3/104), C. glabrata (2/104) and C. pararugosa (1/104). During 
the period of the study, a higher frequency of isolates of C. non-albicans (63.55%) (p = 0.0286) was verified. In this study we verified 
the increase of the non-albicans species throughout the years (mainly in 2009 and 2010). Thus, considering the peculiarities presented 
by Candida species, a correct identification of species is recommended to lead to a faster diagnosis and an efficient treatment.
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INTRODUCTION
Candidemia is an important concern in the clinical medicine 
related to the public health20, mainly because of the high mortality 
rates in children and adults, 30% and 50% respectively38. The risk 
factors for the acquisition of this infection are similar in both ages and 
include a long-term hospitalization in an Intensive Care Unit, previous 
bacterial infection, central venous catheter use, parenteral nutrition and 
immunosuppression. The yeasts of the genus Candida represent the third/
fourth pathogens responsible for the bloodstream infections10,11,24 and their 
epidemiology has been well studied in the United States and Europe, but 
not in Latin America. In Brazil, the incidence rates are fragmented when 
considering data from all regions of the country10,27.
Although C. albicans remains the most frequent species of yeast 
isolated from bloodstream infections, over the last years the number 
of candidemias caused by non-albicans species has been increasing. 
Being that, some studies have reported that from 40% to 50% of the 
infections are caused by other species of Candida16,31,33. Moreover, 
invasive infections caused by non-albicans species are more difficult to 
be treated due to its eventual innate or acquired resistance to antifungal 
agents. Therefore the treatment administration should be based on the 
species-level identification23.
Many epidemiological studies have described the distribution 
of the species, antifungal susceptibility and risk factors in the adult 
population10,33. However, there are few studies about candidemia in 
the pediatric population30,34. Some studies, done in hospitals from 
different geographic regions, report that the most frequent species that 
cause bloodstream infections in pediatric patients are C. albicans and 
C. parapsilosis16,28. In adults, the most frequent isolated species are C. 
albicans, C. glabrata, C. parapsilosis, C. tropicalis and C. krusei28.
In Brazil, the most commonly isolated species in pediatric patients 
are C. albicans, C. parapsilosis and C. tropicalis. In adult patients the 
most common species are the same as in pediatric patients, except 
because of the species C. tropicalis that is the second most frequent 
species in adults10. This high isolation of C. parapsilosis in pediatric 
patients could be explained by the fact that this species is related to 
prematurity, presence of central venous catheters and the use of total 
parenteral nutrition30.
Anatomical and physiological differences between the pediatric 
and adult patients change the susceptibility to infections caused by 
different species of Candida, which therefore influences the antifungal 
treatment approach, including issues related to the toxicity of the drugs, 
pharmacokinetic and dosage41.
Considering the existence of a restricted amount of data to guide the 
clinical decisions to child patients with invasive fungal infections when 
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compared to adults with similar infections, this study had as its objective 
to evaluate the frequency of the yeast species isolated from blood during 
four years in a pediatric hospital in São Paulo, Brazil.
PATIENTS
From 2007 to 2010, yeasts isolated from blood of 104 patients, 
represented by children from five to 11 years old, were studied. Being 
that, each isolated represented a different episode of candidemia. The 
patients were hospitalized in a tertiary infant hospital with 90 hospital 
beds located in the city of São Paulo, Brazil.
MATERIAL AND METHODS
Isolate Process: The blood was seeded in a biphasic culture 
medium BACTEC (Difcotm, USA). Once the fungal growth was 
detected, the medium was seeded in Sabouraud dextrose agar added 
to chloramphenicol to the yeasts isolation, after that it was seeded in a 
CHROmagar® Candida Chromogenic Medium to ensure the purity of the 
isolates and then phenotypically identified.
Phenotypic identification: The conventional identification of all the 
isolates was performed according to the protocol of KURTZMAN et al.20, 
using the germ tube test, microculture, auxanogram and zymogram. The 
phenotypic identification between C. albicans and C. dubliniensis was 
performed evaluating the colony color in a CHROmagar® medium, the 
thermotolerance34 and the growth in a hypertonic medium3.
Genotypic identification: The molecular technique was used to the 
complex C. parapsilosis and for the differentiation of C. albicans and 
C. dubliniensis. 
DNA extraction: The DNA extraction from the culture was carried 
out using the PrepManTM Ultra Sample Preparation reagent Quick 
Reference Card kit (Applied Biosystems, USA), according to the 
commercial protocol.
Differentiation of the complex C. parapsilosis (C. parapsilosis sensu 
stricto, C. orthopsilosis, C. metapsilosis): To the differentiation of the 
complex C. parapsilosis (C. parapsilosis sensu stricto, C. orthopsilosis 
and C. metapsilosis) a Ribosomal DNA ITS sequencing was performed37. 
The amplification of the ITS-rDNA region was accomplished using the 
universal primers V9G / LS26613 and the Big Dye terminator 3.1 kit 
(Applied Biosystems, USA). The edition of the nucleotide sequences 
was performed and analyzed by comparing them with the sequences 
available in the GenBank using the BLASTn (http://blast.ncbi.nlm.nih.
gov/Blast.cgi). 
Differentiation between C. albicans and C. dubliniensis: It was 
carried out according to MANNARELLI & KURTZMAN22. The PCR 
was performed with two pairs of specific primers: one pair for C. 
dubliniensis (sense CDU2 and anti-sense NL4CAL) and another pair 
for C. albicans (sense CAL5 and anti-sense: NL4CAL). The presence 
or not of amplified fragments was visualized by using the agarose gel 
electrophoresis.
Quality control: To control the quality of the phenotypic and 
genotypic methods, the strain patterns used were: ATCC 64548 (C. 
albicans), ATCC 777 (C. dubliniensis), C. parapsilosis (ATCC 22019), 
C. orthopsilosis (ATCC 96141) and C. metapsilosis (ATCC 96143).
Statistical analysis: Quantitative variables were analyzed by the 
unpaired Student’s t test or Mann-Whitney (Prism version 5.0, GraphPad 
Software Inc., La Jolla, CA, USA). A p value < 0.05 was considered to 
be statistically significant.
RESULTS
During the period of the study, a total of 104 yeast strains were 
isolated from hemocultures. Figure 1 represents the total of yeasts isolated 
from blood per year.
The isolation of C. albicans in the children’s public hospital studied 
was kept in the first two years, with the frequency of 42.3% in 2007 and 
48.3% in 2008. In 2009 we had a decrease in the isolation rate (21.7%) 
followed by an increase in 2010 (36%). The isolation of C. non-albicans 
has always been higher than the one verified for C. albicans (p = 0.0286) 
and differently from these species, we had a considerable increase in the 
isolation rate for non-albicans species in the last two periods. The change 
in the numbers of isolates of C. albicans and non-albicans from 2007 to 
2010 can be observed in the Figure 2.
In the four years of this study, the total frequency of identified species 
Fig. 1 - Number of strains and species isolated from blood of 104 pediatric patients, 
hospitalized in a children´s public hospital, from 2007 to 2010.
Fig. 2 - Frequency of isolates of C. albicans and non-abicans per year in a children’s public 
hospital.
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of Candida were: 37.5% of C. albicans (39/104), 24.03% of C. tropicalis 
(25/104), 22.11% of C. parapsilosis (23/104), 5.8% of Pichia anomala 
(6/104), 4.8% of C. guilliermondii (5/104), 2.88% of C. krusei (3/104), 
1.92% of C. glabrata (2/104) and 0.96% of C. pararugosa (1/104). In 
the genotypic testing for differentiation molecular of C. albicans and C. 
dubliniensis and C. parapsilosis complex, the result was consistent with 
C. albicans and C. parapsilosis in 100% of the samples. The frequency 
of the species per year can be observed in Figure 1.
DISCUSSION
Candida albicans is an etiologic agent in about 40-60% of the 
bloodstream infections in pediatric patients14,28. Studies have reported 
an increase in the rate of infections caused by non-albicans species6. In 
research, done in a pediatric hospital in the USA which had 97 patients 
studied, species of Candida (being the most frequent C. albicans and 
C. parapsilosis) were the most commonly isolated among fungemic 
patients, present in 91% of the cases. The species of Candida more 
commonly isolated from blood have changed along the time. In general, 
C. albicans represents 60% of the cases of isolates from blood between 
1991 and 1996 and 48% of the isolates between 1997 and 2001, what 
was in accordance in the groups of ages1. We emphasize in our study 
that 104 children with fungemia were observed in a shorter period than 
the study previously mentioned.
In another study performed in adults and pediatric patients with 
candidemia in a hospital in Porto Rico, the non-albicans species 
represented around 83% of the isolates; meanwhile C. albicans was 
responsible for 17% of the cases12. In our study, C. non-albicans (62.5%) 
were also more isolated than C. albicans (37.5%). We noticed that in 
2007 C. albicans represented 42.3% of the isolates, in 2008 we had 
a small increase of isolates of C. albicans (48.3%), but in 2009 and 
2010 we had a decrease of isolates of these species, 21.7% and 36% 
respectively. The increase of the isolation rates of non-albicans species 
in patients with candidemia in Brazilian hospitals has been reported 
for a while9,31. Different authors have also reported an increase in the 
incidence of candidemia caused by non-albicans species, represented 
by C. parapsilosis, C. glabrata, C. krusei and C. tropicalis. These 
authors affirmed that, however in the last years C. albicans has been 
responsible for more than a half of the cases of candidemias, the rates of 
infections caused by non-albicans species have slowly increased18,25,41. In 
epidemiology, this could be associated with severe immunosuppression 
or illness, prematurity, exposure to broad-spectrum antibiotics, older 
patients and selective pressure exerted by prophylactic antifungals in 
patients at high risk of developing invasive fungal infections35.
Recent studies have reported that C. tropicalis is one of the species 
that most frequently causes urinary tract infections and candidemia, 
especially in patients with cancer26.
Recent studies evinced that the increase of C. parapsilosis incidence 
may be explained by some relevant factors such as parenteral nutrition and 
the use of central venous catheters, and this is explained by the fact that 
this species has the facility to form biofilm2,19. However, possible sources of 
infections and routes of transmission of infections caused by C. parapsilosis 
are not always easily identified and in some cases the epidemiology of the 
infections remains undercover5. Therefore, the epidemiological relevance 
of this study should be highlighted considering that C. parapsilosis was 
one of the most frequently isolated species and had our special attention.
Comparing nowadays with the 1980’s, we can notice that, at present, 
there is a higher frequency of species albicans causing bloodstream 
infections as relevant pathogens like C. glabrata in the USA. Meanwhile, 
in Europe, Canada and Latin America, C. parapsilosis and C. tropicalis are 
the most frequent species responsible for causing bloodstream infections28.
The increase of fungemias caused by non-albicans species like C. 
glabrata and C. krusei, is really relevant to the therapy. C. krusei has an 
inherent resistance to fluconazole and C. glabrata is relatively resistant 
to fluconazole, but fluconazole is the most frequently chosen antifungal 
drug to be used in this cases.
C. guilliermondii has also been isolated in our study. However, 
infections caused by C. guilliermondii are not common. They occurred in 
patients with cancer, hematological neoplasias as nosocomial infections 
by the use of central venous catheter having a high mortality rate40.
Blood, skin, nails, tissues and, less frequent urine and genital tract, 
represent the most common places where the fungi have been more 
frequently isolated as a possible pathogen36.
Regarding the P. anomala strains, it is highlighted in a previous 
study that it had already been isolated from a child patient in a pediatric 
hospital30. PASQUALOTTO et al.32, in another study carried out in a 
pediatric hospital in Brazil, from October 2002 to December 2004, 
an outbreak of P. anomala had been detected. Seventeen patients 
had developed fungemia due to this species and molecular studies 
demonstrated that this outbreak was caused by just one strain. This yeast 
was not isolated, neither from the health professionals’ hands nor from 
the environment.
In India, a hospital outbreak caused by P. anomala in a 23-month 
period (from April 1996 to February 1998), that had the spread from 
the fungi on the health professionals’ hands, led to the commission of 
the hospital infection control to have a strict and educational control 
to improve the hand washing. Analyzing the potential risk factors to 
infections by P. anomala in children, we verified that some of these factors 
are: prematurity, very low-weight, a long-term hospitalization8, the use 
of central venous catheters, total parenteral nutrition, lipid emulsion, 
and the previous use of antimicrobial and other invasive procedures4.
Based on the finding of this study and the literature, we could notice 
the relevance of studying nosocomial infections cases by yeasts, especially 
from the genus Candida. We verified the increase of the non-albicans 
species throughout the years (mainly in 2009 and 2010). The non-albicans 
species cases have been increasing year after year in these nosocomial 
infection cases and concerning all these data, it is highlighted a correct 
species-level identification to lead to a fast diagnosis and efficient treatment.
RESUMO
Fungemia por espécies de Candida em Hospital Pediátrico da 
cidade de São Paulo, Brasil: estudo no período de 2007 a 2010 
Candidemia permance como a maior causa de morbidade e 
mortalidade em ambiente hospitalar. A epidemiologia de infecções por 
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Candida vem se alterando, principalmente em relação ao número de 
episódios causados por espécies não-albicans. Este estudo teve como 
objetivo avaliar a frequência, em um período de quatro anos, de leveduras 
do gênero Candida isoladas de sangue de pacientes pediátricos internados 
em hospital público da cidade de São Paulo, Brasil. Neste período foram 
isoladas leveduras de sangue de 104 pacientes, e as espécies de Candida 
identificadas, por métodos fenotípicos e genotípicos, foram: C. albicans 
(39/104), C. tropicalis (25/104), C. parapsilosis (23/104), Pichia anomala 
(6/104), C. guilliermondii (5/104), C. krusei (3/104), C. glabrata (2/104) 
e C. pararugosa (1/104). Em todo período do estudo foi observada maior 
frequência de isolamento de C. não-albicans (63,55%) (p = 0,0286). 
Neste estudo verificou-se aumento das espécies não-albicans ao longo 
dos anos (principalmente em 2009 e 2010), assim, ressalta-se que correta 
identificação em nível de espécie é recomendável, para que isso acarrete 
diagnóstico rápido e tratamento eficaz.
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